Suppr超能文献

埃及经典 KD 治疗失败后,MAD 在癫痫儿童中的应用经验。

Experience with MAD on children with epilepsy in Egypt after classic KD failure.

机构信息

Pediatrics Department Children's Hospital, Ain-Shams University, Cairo, Egypt.

出版信息

Acta Neurol Scand. 2018 Feb;137(2):195-198. doi: 10.1111/ane.12856. Epub 2017 Oct 16.

Abstract

BACKGROUND AND AIM

Modified Atkins diet (MAD) is a less restrictive type of ketogenic diet (KD) as compared to the classic one. The aim of this study was to evaluate the impact of 9 months MAD treatment on the growth and seizure control in patients with intractable epilepsy as well as the quality of life (QoL) of their mothers.

SUBJECTS AND METHODS

The study included 15 patients with intractable epilepsy who could not tolerate their classic KD management plan. From the 15 recruited cases, only seven patients completed this nine months prospective study. After neurological reassessment, the patients were prescribed MAD tailored from the local Egyptian ingredients. Arabic translation of the WHO Quality of life Instruments (WHOQOL-BREF) scale was calculated for the mothers initially and 9 months later. Daily seizure frequency with severity assessment by Chalfont scale was recorded as well as monthly weight and length throughout the study period.

RESULTS

Mothers 'QoL in all WHOQOL-BREF domains significantly improved (P < .001) after nine months follow-up coupled by significant decrease in Chalfont scores from 51.00 ± 15.45 to 20.57 ± 21.45 and daily seizure frequency from 13.29 ± 6.99 to 2.71 ± 3.68. Regarding anthropometric data, there was significant increase in patients' weight and length as well as in the z-score for weight and length.

CONCLUSION

After nine months of MAD, growth and seizure parameters significantly improved in the intractable epilepsy patients as well as their mothers& QoL. We thus recommend MAD as a more flexible alternative in intractable epilepsy patients who can not tolerate classic KD.

摘要

背景与目的

相较于经典生酮饮食(KD),改良阿特金斯饮食(MAD)的限制更少。本研究旨在评估 9 个月 MAD 治疗对耐药性癫痫患者的生长和癫痫控制以及其母亲生活质量(QoL)的影响。

受试者与方法

该研究纳入了 15 名无法耐受经典 KD 管理方案的耐药性癫痫患者。在招募的 15 例患者中,仅有 7 例完成了这项为期 9 个月的前瞻性研究。在神经学重新评估后,为患者开出了基于当地埃及成分的 MAD 处方。最初和 9 个月后,为母亲计算了世界卫生组织生活质量量表(WHOQOL-BREF)的阿拉伯语翻译版本。还记录了 Chalfont 量表评估的每日癫痫发作频率和严重程度,以及整个研究期间的每月体重和身长。

结果

母亲在所有 WHOQOL-BREF 领域的 QoL 在 9 个月的随访后显著改善(P<.001),Chalfont 评分从 51.00±15.45 降至 20.57±21.45,每日癫痫发作频率从 13.29±6.99 降至 2.71±3.68。关于人体测量数据,患者的体重和身长以及体重和身长的 z 评分均显著增加。

结论

在 MAD 治疗 9 个月后,耐药性癫痫患者的生长和癫痫参数以及其母亲的 QoL 均显著改善。因此,我们推荐 MAD 作为无法耐受经典 KD 的耐药性癫痫患者的一种更灵活的替代方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验